|
[1]
|
Sundqvist, M., Gibson, K.M., Bowers, S.M., Niemietz, I. and Brown, K.L. (2020) Anti-Neutrophil Cytoplasmic Antibodies (ANCA): Antigen Interactions and Downstream Effects. Journal of Leukocyte Biology, 108, 617-626. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Charles, L.A., Caldas, M.L.R., Falk, R.J., Terrell, R.S. and Jennette, J.C. (1991) Antibodies against Granule Proteins Activate Neutrophils in Vitro. Journal of Leukocyte Biology, 50, 539-546. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Niles, J., McCluskey, R., Ahmad, M. and Arnaout, M. (1989) Wegener’s Granulomatosis Autoantigen Is a novel Neutrophil Serine Proteinase [See Comments]. Blood, 74, 1888-1893. [Google Scholar] [CrossRef]
|
|
[4]
|
Falk, R.J. and Jennette, J.C. (1988) Anti-neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic Glomerulonephritis. New England Journal of Medicine, 318, 1651-1657. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Geetha, D. and Jefferson, J.A. (2020) Anca-associated Vasculitis: Core Curriculum 2020. American Journal of Kidney Diseases, 75, 124-137. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Sacoto, G., Boukhlal, S., Specks, U., Flores-Suárez, L.F. and Cornec, D. (2020) Lung Involvement in Anca-Associated Vasculitis. La Presse Médicale, 49, Article ID: 104039. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Zhao, W., Wang, Z., Shi, R., Zhu, Y., Zhang, S., Wang, R., et al. (2022) Environmental Factors Influencing the Risk of Anca-Associated Vasculitis. Frontiers in Immunology, 13, Article 991256. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Sebastiani, M., Manfredi, A., Vacchi, C., et al. (2020) Epidemiology and Management of Interstitial Lung Disease in AN-CA-Associated Vasculitis. Clinical and Experimental Rheumatology, 124, 221-231.
|
|
[9]
|
Kadura, S. and Raghu, G. (2021) Antineutrophil Cytoplasmic Antibody-Associated Interstitial Lung Disease: A Review. European Respiratory Review, 30, Article ID: 210123. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Furuta, S., Chaudhry, A.N., Hamano, Y., Fujimoto, S., Nagafuchi, H., Makino, H., et al. (2014) Comparison of Phenotype and Outcome in Microscopic Polyangiitis between Europe and Japan. The Journal of Rheumatology, 41, 325-333. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
West, S., Arulkumaran, N., Ind, P.W. and Pusey, C.D. (2013) Diffuse Alveolar Haemorrhage in Anca-Associated Vasculitis. Internal Medicine, 52, 5-13. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Karras, A. (2018) Microscopic Polyangiitis: New Insights into Pathogenesis, Clinical Features and Therapy. Seminars in Respiratory and Critical Care Medicine, 39, 459-464. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Unizony, S., Villarreal, M., Miloslavsky, E.M., Lu, N., Merkel, P.A., Spiera, R., et al. (2016) Clinical Outcomes of Treatment of Anti-Neutrophil Cytoplasmic Antibody (Anca)-Associated Vasculitis Based on ANCA Type. Annals of the Rheumatic Diseases, 75, 1166-1169. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
White, J. and Dubey, S. (2023) Eosinophilic Granulomatosis with Polyangiitis: A Review. Autoimmunity Reviews, 22, Article ID: 103219. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lin, Y., Zheng, W., Tian, X., Zhang, X., Zhang, F. and Dong, Y. (2009) Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Complicated with Diffuse Alveolar Hemorrhage. JCR: Journal of Clinical Rheumatology, 15, 341-344. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Martínez-Martínez, M.U., Oostdam, D.A.H. and Abud-Mendoza, C. (2017) Diffuse Alveolar Hemorrhage in Autoimmune Diseases. Current Rheumatology Reports, 19, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Jariwala, M. and Laxer, R.M. (2020) Childhood GPA, EGPA, and MPA. Clinical Immunology, 211, Article ID: 108325. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Sacri, A., Chambaraud, T., Ranchin, B., Florkin, B., See, H., Decramer, S., et al. (2015) Clinical Characteristics and Outcomes of Childhood-Onset Anca-Associated Vasculitis: A French Nationwide Study. Nephrology Dialysis Transplantation, 30, i104-i112. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Grisaru, S., Yuen, G.W.H., Miettunen, P.M. and Hamiwka, L.A. (2009) Incidence of Wegener’s Granulomatosis in Children. The Journal of Rheumatology, 37, 440-442. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Bernardi, S., Seugé, L. and Boyer, O. (2022) Anca-Associated Vasculitis in Children. Nephrology Dialysis Transplantation, 38, 66-69. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
丁桂霞, 赵非, 吴红梅, 等. 儿童抗中性粒细胞胞浆抗体相关性小血管炎两例分析[C]//浙江省医学会儿科学分会,江苏省医学会儿科学分会, 上海市医学会儿科学分会. 第十三届江浙沪儿科学术会议暨2016年浙江省医学会儿科学学术年会论文汇编. 南京: 南京医科大学附属南京儿童医院, 2016: 970.
|
|
[22]
|
邹丽霞, 卢美萍, 徐益萍, 等. 肺脏受累的儿童抗中性粒细胞胞浆抗体相关小血管炎8例临床回顾分析[C]//浙江省医学会儿科学分会. 2018年浙江省医学会儿科学分会学术年会论文汇编. 杭州: 浙江大学医学院附属儿童医院, 2018: 176-177.
|
|
[23]
|
邹丽霞, 卢美萍, 徐益萍, 等. 儿童抗中性粒细胞胞浆抗体相关性血管炎10例病例系列报告[J]. 中国循证儿科杂志, 2020, 15(4): 297-301.
|
|
[24]
|
刘京祺, 李永珍, 帅兰军, 等. 儿童抗中性粒细胞胞质抗体相关性血管炎临床特征分析[J]. 中国当代儿科杂志, 2024, 26(8): 823-828.
|
|
[25]
|
Nakazawa, D., Masuda, S., Tomaru, U. and Ishizu, A. (2018) Pathogenesis and Therapeutic Interventions for Anca-Associated Vasculitis. Nature Reviews Rheumatology, 15, 91-101. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Alba, M., Jennette, J. and Falk, R. (2018) Pathogenesis of Anca-Associated Pulmonary Vasculitis. Seminars in Respiratory and Critical Care Medicine, 39, 413-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Alberici, F., Martorana, D., Bonatti, F., et al. (2014) Genetics of ANCA-Associated Vasculitides: HLA and beyond. Clinical and Experimental Rheumatology, 32, S90-S97.
|
|
[28]
|
Haubitz, M., Dhaygude, A. and Woywodt, A. (2009) Mechanisms and Markers of Vascular Damage in Anca-Associated Vasculitis. Autoimmunity, 42, 605-614. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Trivioli, G., Marquez, A., Martorana, D., Tesi, M., Kronbichler, A., Lyons, P.A., et al. (2022) Genetics of Anca-Associated Vasculitis: Role in Pathogenesis, Classification and Management. Nature Reviews Rheumatology, 18, 559-574. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Biondini, D., Cocconcelli, E., Bernardinello, N., Lorenzoni, G., Rigobello, C., Lococo, S., et al. (2021) Prognostic Role of MUC5B Rs35705950 Genotype in Patients with Idiopathic Pulmonary Fibrosis (IPF) on Antifibrotic Treatment. Respiratory Research, 22, Article No. 98. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Salvati, L., Palterer, B. and Parronchi, P. (2020) Spectrum of Fibrotic Lung Diseases. The New England Journal of Medicine, 383, 958-968.
|
|
[32]
|
Juge, P.A., Lee, J.S., Ebstein, E., et al. (2018) MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. The New England Journal of Medicine, 379, 2209-2219.
|
|
[33]
|
Namba, N., Kawasaki, A., Sada, K., Hirano, F., Kobayashi, S., Yamada, H., et al. (2019) Association of MUC5B Promoter Polymorphism with Interstitial Lung Disease in Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Annals of the Rheumatic Diseases, 78, 1144-1146. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
韦素珍. 广西汉族人群Toll样受体2(597T/C)基因多态性与ANCA相关性小血管炎相关研究[D]: [硕士学位论文]. 南宁: 广西医科大学, 2016.
|
|
[35]
|
Wu, Z., Xu, J., Sun, F., Chen, H., Wu, Q., Zheng, W., et al. (2014) Single Nucleotide Polymorphisms in the Toll-Like Receptor 2 (TLR2) Gene Are Associated with Microscopic Polyangiitis in the Northern Han Chinese Population. Modern Rheumatology, 25, 224-229. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
项新. 广西汉族人群TGFβ1基因-509C/T多态性与ANCA相关性系统性小血管炎肾损害相关关系的研究[D]: [硕士学位论文]. 南宁: 广西医科大学, 2007.
|
|
[37]
|
Pendergraft, W.F., Preston, G.A., Shah, R.R., Tropsha, A., Carter, C.W., Jennette, J.C., et al. (2003) Autoimmunity Is Triggered by CPR-3(105-201), a Protein Complementary to Human Autoantigen Proteinase-3. Nature Medicine, 10, 72-79. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Tadema, H., Heeringa, P. and Kallenberg, C.G. (2011) Bacterial Infections in Wegener’s Granulomatosis: Mechanisms Potentially Involved in Autoimmune Pathogenesis. Current Opinion in Rheumatology, 23, 366-371. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Stegeman, C.A., Tervaert, J.W.C., Sluiter, W.J., Manson, W.L., de Jong, P.E. and Kallenberg, C.G.M. (1994) Association of Chronic Nasal Carriage of staphylococcus Aureus and Higher Relapse Rates in Wegener Granulomatosis. Annals of Internal Medicine, 120, 12-17. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Popa, E.R., Stegeman, C.A., Abdulahad, W.H., van der Meer, B., Arends, J., Manson, W.M., et al. (2007) Staphylococcal Toxic-Shock-Syndrome-Toxin-1 as a Risk Factor for Disease Relapse in Wegener’s Granulomatosis. Rheumatology, 46, 1029-1033. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Fathallah, N., Ouni, B., Mokni, S., Baccouche, K., Atig, A., Ghariani, N., et al. (2019) Vascularites médicamenteuses: À propos d’une série de 13 cas. Therapies, 74, 347-354. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Weng, C. and Liu, Z. (2019) Drug-induced Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. Chinese Medical Journal, 132, 2848-2855. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Shakoor, M.T., Birkenbach, M.P. and Lynch, M. (2021) Anca-Associated Vasculitis Following Pfizer-Biontech COVID-19 Vaccine. American Journal of Kidney Diseases, 78, 611-613. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Yu, F., Chen, M., Gao, Y., Wang, S., Zou, W., Zhao, M., et al. (2007) Clinical and Pathological Features of Renal Involvement in Propylthiouracil-Associated Anca-Positive Vasculitis. American Journal of Kidney Diseases, 49, 607-614. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Kitching, A.R., Anders, H., Basu, N., Brouwer, E., Gordon, J., Jayne, D.R., et al. (2020) Anca-Associated Vasculitis. Nature Reviews Disease Primers, 6, Article No. 71. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Chen, M., Jayne, D.R.W. and Zhao, M. (2017) Complement in Anca-Associated Vasculitis: Mechanisms and Implications for Management. Nature Reviews Nephrology, 13, 359-367. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Misra, D.P., Thomas, K.N., Gasparyan, A.Y. and Zimba, O. (2021) Mechanisms of Thrombosis in Anca-Associated Vasculitis. Clinical Rheumatology, 40, 4807-4815. [Google Scholar] [CrossRef] [PubMed]
|
|
[48]
|
Falk, R.J., Terrell, R.S., Charles, L.A. and Jennette, J.C. (1990) Anti-Neutrophil Cytoplasmic Autoantibodies Induce Neutrophils to Degranulate and Produce Oxygen Radicals in Vitro. Proceedings of the National Academy of Sciences of the United States of America, 87, 4115-4119. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Kessenbrock, K., Krumbholz, M., Schönermarck, U., Back, W., Gross, W.L., Werb, Z., et al. (2009) Netting Neutrophils in Autoimmune Small-Vessel Vasculitis. Nature Medicine, 15, 623-625. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Thiam, H.R., Wong, S.L., Wagner, D.D. and Waterman, C.M. (2020) Cellular Mechanisms of Netosis. Annual Review of Cell and Developmental Biology, 36, 191-218. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Clark, S.R., Ma, A.C., Tavener, S.A., McDonald, B., Goodarzi, Z., Kelly, M.M., et al. (2007) Platelet TLR4 Activates Neutrophil Extracellular Traps to Ensnare Bacteria in Septic Blood. Nature Medicine, 13, 463-469. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Fuchs, T.A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D.D., et al. (2010) Extracellular DNA Traps Promote Thrombosis. Proceedings of the National Academy of Sciences of the United States of America, 107, 15880-15885. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Frangou, E., Vassilopoulos, D., Boletis, J. and Boumpas, D.T. (2019) An Emerging Role of Neutrophils and Netosis in Chronic Inflammation and Fibrosis in Systemic Lupus Erythematosus (SLE) and Anca-Associated Vasculitides (AAV): Implications for the Pathogenesis and Treatment. Autoimmunity Reviews, 18, 751-760. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Guilpain, P., Chéreau, C., Goulvestre, C., Servettaz, A., Montani, D., Tamas, N., et al. (2010) The Oxidation Induced by Antimyeloperoxidase Antibodies Triggers Fibrosis in Microscopic Polyangiitis. European Respiratory Journal, 37, 1503-1513. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Negreros, M. and Flores-Suárez, L.F. (2021) A Proposed Role of Neutrophil Extracellular Traps and Their Interplay with Fibroblasts in Anca-Associated Vasculitis Lung Fibrosis. Autoimmunity Reviews, 20, Article ID: 102781. [Google Scholar] [CrossRef] [PubMed]
|
|
[56]
|
Nakano, Y., Yang, I.V., Walts, A.D., Watson, A.M., Helling, B.A., Fletcher, A.A., et al. (2016) MUC5B Promoter Variant Rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 193, 464-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[57]
|
Chintagari, N.R., Jana, S. and Alayash, A.I. (2016) Oxidized Ferric and Ferryl Forms of Hemoglobin Trigger Mitochondrial Dysfunction and Injury in Alveolar Type I Cells. American Journal of Respiratory Cell and Molecular Biology, 55, 288-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
Kettritz, R. (2014) With Complements from ANCA Mice. Journal of the American Society of Nephrology, 25, 207-209. [Google Scholar] [CrossRef] [PubMed]
|
|
[59]
|
Lange, C., Csernok, E., Moosig, F., et al. (2017) Immune Stimulatory Effects of Neutrophil Extracellular Traps in Granulomatosis with Polyangiitis. Clinical and Experimental Rheumatology, 103, 33-39.
|
|
[60]
|
Schreiber, A., Xiao, H., Jennette, J.C., Schneider, W., Luft, F.C. and Kettritz, R. (2009) C5a Receptor Mediates Neutrophil Activation and Anca-Induced Glomerulonephritis. Journal of the American Society of Nephrology, 20, 289-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[61]
|
Foreman, K.E., Vaporciyan, A.A., Bonish, B.K., Jones, M.L., Johnson, K.J., Glovsky, M.M., et al. (1994) C5a-Induced Expression of P-Selectin in Endothelial Cells. Journal of Clinical Investigation, 94, 1147-1155. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Schraufstatter, I.U., Trieu, K., Sikora, L., Sriramarao, P. and DiScipio, R. (2002) Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells. The Journal of Immunology, 169, 2102-2110. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Brilland, B., Garnier, A., Chevailler, A., Jeannin, P., Subra, J. and Augusto, J. (2020) Complement Alternative Pathway in Anca-Associated Vasculitis: Two Decades from Bench to Bedside. Autoimmunity Reviews, 19, Article ID: 102424. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Moiseev, S., Lee, J.M., Zykova, A., Bulanov, N., Novikov, P., Gitel, E., et al. (2020) The Alternative Complement Pathway in Anca-Associated Vasculitis: Further Evidence and a Meta-analysis. Clinical and Experimental Immunology, 202, 394-402. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Griese, M. (2018) Chronic Interstitial Lung Disease in Children. European Respiratory Review, 27, Article ID: 170100. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Podolanczuk, A.J., Wong, A.W., Saito, S., Lasky, J.A., Ryerson, C.J. and Eickelberg, O. (2021) Update in Interstitial Lung Disease 2020. American Journal of Respiratory and Critical Care Medicine, 203, 1343-1352. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Nozu, T., Kondo, M., Suzuki, K., Tamaoki, J. and Nagai, A. (2008) A Comparison of the Clinical Features of Anca-Positive and Anca-Negative Idiopathic Pulmonary Fibrosis Patients. Respiration, 77, 407-415. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Hosoda, C., Baba, T., Hagiwara, E., Ito, H., Matsuo, N., Kitamura, H., et al. (2016) Clinical Features of Usual Interstitial Pneumonia with Anti‐Neutrophil Cytoplasmic Antibody in Comparison with Idiopathic Pulmonary Fibrosis. Respirology, 21, 920-926. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Yamaguchi, K., Yamaguchi, A., Ito, M., Wakamatsu, I., Itai, M., Muto, S., et al. (2022) Clinical Differences among Patients with Myeloperoxidase–antineutrophil Cytoplasmic Antibody-Positive Interstitial Lung Disease. Clinical Rheumatology, 42, 479-488. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Sakamoto, S., Suzuki, A., Homma, S., Usui, Y., Shimizu, H., Sekiya, M., et al. (2023) Outcomes and Prognosis of Progressive Pulmonary Fibrosis in Patients with Antineutrophil Cytoplasmic Antibody-Positive Interstitial Lung Disease. Scientific Reports, 13, Article No. 17616. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Kronbichler, A., Lee, K.H., Denicolò, S., et al. (2020) Immunopathogenesis of ANCA-Associated Vasculitis. International Journal of Molecular Sciences, 21, Article 7319.
|
|
[72]
|
Fernandez Casares, M., Gonzalez, A., Fielli, M., Caputo, F., Bottinelli, Y. and Zamboni, M. (2014) Microscopic Polyangiitis Associated with Pulmonary Fibrosis. Clinical Rheumatology, 34, 1273-1277. [Google Scholar] [CrossRef] [PubMed]
|
|
[73]
|
Flores-Suárez, L.F., Ruiz, N., Rivera, L.M.S. and Pensado, L. (2015) Reduced Survival in Microscopic Polyangiitis Patients with Pulmonary Fibrosis in a Respiratory Referral Centre. Clinical Rheumatology, 34, 1653-1654. [Google Scholar] [CrossRef] [PubMed]
|
|
[74]
|
Kronbichler, A., Bajema, I.M., Bruchfeld, A., Mastroianni Kirsztajn, G. and Stone, J.H. (2024) Diagnosis and Management of Anca-Associated Vasculitis. The Lancet, 403, 683-698. [Google Scholar] [CrossRef] [PubMed]
|
|
[75]
|
Scurt, F.G., Bose, K., Hammoud, B., Brandt, S., Bernhardt, A., Gross, C., et al. (2022) Old Known and Possible New Biomarkers of Anca-Associated Vasculitis. Journal of Autoimmunity, 133, Article ID: 102953. [Google Scholar] [CrossRef] [PubMed]
|
|
[76]
|
Conticini, E., d’Alessandro, M., Bergantini, L., Castillo, D., Cameli, P., Frediani, B., et al. (2022) KL-6 in Anca-Associated Vasculitis Patients with and without ILD: A Machine Learning Approach. Biology, 11, Article 94. [Google Scholar] [CrossRef] [PubMed]
|
|
[77]
|
谭立明, 卢晓霞, 张倩, 等. 血清KL-6、DD及CRP在ANCA相关性血管炎合并间质性肺病检测中的临床价值[J]. 中国免疫学杂志, 2021, 37(8): 983-987.
|
|
[78]
|
Iwata, Y., Wada, T., Furuichi, K., Kitagawa, K., Kokubo, S., Kobayashi, M., et al. (2001) Serum Levels of KL-6 Reflect Disease Activity of Interstitial Pneumonia Associated with Anca-Related Vasculitis. Internal Medicine, 40, 1093-1097. [Google Scholar] [CrossRef] [PubMed]
|
|
[79]
|
刘玉鹏, 宣依依, 赵震, 等. 抗中性粒细胞胞浆抗体相关性血管炎合并肺间质病变患者血清KL-6水平分析[J]. 河南医学研究, 2019, 28(7): 1165-1168.
|
|
[80]
|
谢家琪. ANCA相关血管炎合并间质性肺疾病发病率、临床特征及预后分析[D]: [硕士学位论文]. 郑州: 郑州大学, 2021.
|
|
[81]
|
Salvador, F. (2020) ANCA Associated Vasculitis. European Journal of Internal Medicine, 74, 18-28. [Google Scholar] [CrossRef] [PubMed]
|
|
[82]
|
Park, J.A. (2021) Treatment of Diffuse Alveolar Hemorrhage: Controlling Inflammation and Obtaining Rapid and Effective Hemostasis. International Journal of Molecular Sciences, 22, Article 793. [Google Scholar] [CrossRef] [PubMed]
|
|
[83]
|
Colby, T.V. and Specks, U. (1993) Wegener’s granulomatosis in the 1990s—A Pulmonary Pathologist’s Perspective. Monographs Pathology, 36, 195-218.
|
|
[84]
|
Zhou, P., Li, Z., Gao, L., Zhao, B., Que, C., Li, H., et al. (2023) Patterns of Interstitial Lung Disease and Prognosis in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Respiration, 102, 257-273. [Google Scholar] [CrossRef] [PubMed]
|
|
[85]
|
Yamagata, M., Ikeda, K., Tsushima, K., Iesato, K., Abe, M., Ito, T., et al. (2016) Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients with Microscopic Polyangiitis: A Multicenter, Longitudinal, Retrospective Study of One Hundred Fifty Consecutive Hospital‐Based Japanese Patients. Arthritis & Rheumatology, 68, 713-723. [Google Scholar] [CrossRef] [PubMed]
|
|
[86]
|
Seo, J.B., Im, J.G., Chung, J.W., Song, J.W., Goo, J.M., Park, J.H., et al. (2000) Pulmonary Vasculitis: The Spectrum of Radiological Findings. The British Journal of Radiology, 73, 1224-1231. [Google Scholar] [CrossRef] [PubMed]
|
|
[87]
|
Rosenberg, D.M., Weinberger, S.E., Fulmer, J.D., et al. (1980) Functional Correlates of Lung Involvement in Wegener’s Granulomatosis. Use of Pulmonary Function Tests in Staging and Follow-Up. The American Journal of Medicine, 69, 387-394.
|
|
[88]
|
Koldingsnes, W., Jacobsen, E.A., Sildnes, T., Hjalmarsen, A. and Nossent, H.C. (2005) Pulmonary Function and High‐resolution CT Findings Five Years after Disease Onset in Patients with Wegener’s Granulomatosis. Scandinavian Journal of Rheumatology, 34, 220-228. [Google Scholar] [CrossRef] [PubMed]
|
|
[89]
|
Polychronopoulos, V.S., Prakash, U.B.S., Golbin, J.M., Edell, E.S. and Specks, U. (2007) Airway Involvement in Wegener’s Granulomatosis. Rheumatic Disease Clinics of North America, 33, 755-775. [Google Scholar] [CrossRef] [PubMed]
|
|
[90]
|
Hellmich, B. and Jayne, D. (2024) Response To: Correspondence on ‘EULAR Recommendations for the Management of Anca-Associated Vasculitis: 2022 Update’ by Hellmich et al. Annals of the Rheumatic Diseases, 83, e21. [Google Scholar] [CrossRef] [PubMed]
|
|
[91]
|
Jachiet, M., Samson, M., Cottin, V., Kahn, J., Le Guenno, G., Bonniaud, P., et al. (2016) Anti‐Ige Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis with Polyangiitis (Churg‐Strauss): Data on Seventeen Patients. Arthritis & Rheumatology, 68, 2274-2282. [Google Scholar] [CrossRef] [PubMed]
|
|
[92]
|
Celebi Sozener, Z., Gorgulu, B., Mungan, D., Sin, B.A., Misirligil, Z., Aydin, O., et al. (2018) Omalizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): Single-Center Experience in 18 Cases. World Allergy Organization Journal, 11, 39. [Google Scholar] [CrossRef] [PubMed]
|
|
[93]
|
Stone, J.H., Merkel, P.A., Spiera, R., Seo, P., Langford, C.A., Hoffman, G.S., et al. (2010) Rituximab versus Cyclophosphamide for Anca-Associated Vasculitis. New England Journal of Medicine, 363, 221-232. [Google Scholar] [CrossRef] [PubMed]
|
|
[94]
|
Cartin‐Ceba, R., Diaz‐Caballero, L., Al‐Qadi, M.O., Tryfon, S., Fervenza, F.C., Ytterberg, S.R., et al. (2016) Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes. Arthritis & Rheumatology, 68, 1467-1476. [Google Scholar] [CrossRef] [PubMed]
|
|
[95]
|
Kallenberg, C.G. (2015) Pathogenesis and Treatment of ANCA-Associated Vasculitides. Clinical and Experimental Rheumatology, 33, S11-S14.
|
|
[96]
|
Morisset, J. and Lee, J.S. (2019) New Trajectories in the Treatment of Interstitial Lung Disease: Treat the Disease or Treat the Underlying Pattern? Current Opinion in Pulmonary Medicine, 25, 442-449. [Google Scholar] [CrossRef] [PubMed]
|
|
[97]
|
Flaherty, K.R., Wells, A.U., Cottin, V., Devaraj, A., Walsh, S.L.F., Inoue, Y., et al. (2019) Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. New England Journal of Medicine, 381, 1718-1727. [Google Scholar] [CrossRef] [PubMed]
|